BR0311826A - Inibidores da interação gpib-vwf, sua preparação e uso - Google Patents
Inibidores da interação gpib-vwf, sua preparação e usoInfo
- Publication number
- BR0311826A BR0311826A BR0311826-6A BR0311826A BR0311826A BR 0311826 A BR0311826 A BR 0311826A BR 0311826 A BR0311826 A BR 0311826A BR 0311826 A BR0311826 A BR 0311826A
- Authority
- BR
- Brazil
- Prior art keywords
- gpib
- compounds
- preparation
- formula
- vwf
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 108010047303 von Willebrand Factor Proteins 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 102100036537 von Willebrand factor Human genes 0.000 abstract 1
- 229960001134 von willebrand factor Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02012590A EP1369420A1 (en) | 2002-06-06 | 2002-06-06 | Inhibitors of the GPib - vWF interaction |
| PCT/EP2003/005955 WO2003104221A1 (en) | 2002-06-06 | 2003-06-06 | Inhibitors of the gpib -vwf interaction, their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0311826A true BR0311826A (pt) | 2005-03-29 |
Family
ID=29433122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0311826-6A BR0311826A (pt) | 2002-06-06 | 2003-06-06 | Inibidores da interação gpib-vwf, sua preparação e uso |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1369420A1 (OSRAM) |
| JP (1) | JP4455326B2 (OSRAM) |
| AT (1) | ATE353082T1 (OSRAM) |
| AU (1) | AU2003274686A1 (OSRAM) |
| BR (1) | BR0311826A (OSRAM) |
| CA (1) | CA2488193A1 (OSRAM) |
| DE (1) | DE60311578T2 (OSRAM) |
| MX (1) | MXPA04011408A (OSRAM) |
| WO (1) | WO2003104221A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR043507A1 (es) * | 2003-03-14 | 2005-08-03 | Lundbeck & Co As H | Derivados de anilina sustituidos y composiciones farmaceuticas |
| JP2006520333A (ja) * | 2003-03-14 | 2006-09-07 | ハー・ルンドベック・アクチエゼルスカベット | 置換されたアニリン誘導体 |
| US7932272B2 (en) | 2003-09-30 | 2011-04-26 | Eisai R&D Management Co., Ltd. | Antifungal agent containing heterocyclic compound |
| EP1782811A4 (en) * | 2004-08-09 | 2010-09-01 | Eisai R&D Man Co Ltd | INNOVATIVE ANTIPALUDITIC AGENT CONTAINING A HETEROCYCLIC COMPOUND |
| JP4874958B2 (ja) | 2005-03-30 | 2012-02-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピリジン誘導体を含有する抗真菌剤 |
| TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
| EP2065377B1 (en) | 2006-09-21 | 2011-11-23 | Eisai R&D Management Co., Ltd. | Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| JPWO2008136279A1 (ja) | 2007-04-27 | 2010-07-29 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環置換ピリジン誘導体の塩またはその結晶 |
| TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| EP3103791B1 (en) | 2007-06-27 | 2018-01-31 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| CA2692153A1 (en) | 2007-06-27 | 2009-01-08 | Richard W. Heidebrecht, Jr. | Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors |
| US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
| WO2012051117A2 (en) * | 2010-10-11 | 2012-04-19 | The Board Of Trustees Of The Leland Stanford Junior University | Substituted benzamides and their uses |
| CA2873701A1 (en) | 2012-04-12 | 2013-10-17 | Auckland Uniservices Limited | Substituted benzamides and their uses |
| JP2023078557A (ja) * | 2021-11-26 | 2023-06-07 | 学校法人東海大学 | フォンヴィルブランド因子と血小板との結合を阻害するための医薬組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW301607B (OSRAM) * | 1993-03-09 | 1997-04-01 | Takeda Pharm Industry Co Ltd | |
| US5919776A (en) * | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
| AU5812498A (en) * | 1996-12-20 | 1998-07-17 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
-
2002
- 2002-06-06 EP EP02012590A patent/EP1369420A1/en not_active Withdrawn
-
2003
- 2003-06-06 MX MXPA04011408A patent/MXPA04011408A/es unknown
- 2003-06-06 BR BR0311826-6A patent/BR0311826A/pt not_active IP Right Cessation
- 2003-06-06 DE DE60311578T patent/DE60311578T2/de not_active Expired - Lifetime
- 2003-06-06 CA CA002488193A patent/CA2488193A1/en not_active Abandoned
- 2003-06-06 EP EP03740199A patent/EP1509516B1/en not_active Expired - Lifetime
- 2003-06-06 AT AT03740199T patent/ATE353082T1/de not_active IP Right Cessation
- 2003-06-06 WO PCT/EP2003/005955 patent/WO2003104221A1/en not_active Ceased
- 2003-06-06 AU AU2003274686A patent/AU2003274686A1/en not_active Abandoned
- 2003-06-06 JP JP2004511291A patent/JP4455326B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005528459A (ja) | 2005-09-22 |
| CA2488193A1 (en) | 2003-12-18 |
| JP4455326B2 (ja) | 2010-04-21 |
| EP1369420A1 (en) | 2003-12-10 |
| DE60311578T2 (de) | 2007-11-15 |
| AU2003274686A8 (en) | 2003-12-22 |
| AU2003274686A1 (en) | 2003-12-22 |
| ATE353082T1 (de) | 2007-02-15 |
| EP1509516A1 (en) | 2005-03-02 |
| DE60311578D1 (de) | 2007-03-22 |
| MXPA04011408A (es) | 2005-09-30 |
| EP1509516B1 (en) | 2007-01-31 |
| WO2003104221A1 (en) | 2003-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0311826A (pt) | Inibidores da interação gpib-vwf, sua preparação e uso | |
| BR0016396A (pt) | Novos antagonistas do receptor p2x7 para uso no tratamento de doenças inflamatórias, imunes ou cardiovasculares | |
| EE03969B1 (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
| BR9808998A (pt) | Imidazóis substituìdos úteis no tratamento de doenças inflamatórias | |
| DE69034103D1 (de) | Imidazoalkensäure | |
| CY1107871T1 (el) | Παραγωγα πυριμιδινης και η χρηση τους ως ρυθμιστων cb2 | |
| EE05287B1 (et) | Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
| CY1110177T1 (el) | Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης | |
| CY1108067T1 (el) | Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης | |
| NO20026064D0 (no) | Nye forbindelser | |
| DE69818831D1 (de) | Indolderivate als mcp-1 rezeptor antagonisten | |
| ATE427936T1 (de) | Substituierte piperidin-verbindungen als modulatoren der chemokine receptor aktivitat | |
| SE8804629D0 (sv) | New therapeutically active compounds | |
| CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
| NO904666D0 (no) | Kondenserte polycykliske forbindelser, fremgangsmaater forfremstilling derav og anvendelse som paf-antagonister, antihistaminer og/eller antiinflammatoriske midler. | |
| BR0208741A (pt) | Derivados de piperidina | |
| CY1104993T1 (el) | 4-(πιπεριδυλ- και πυρρολιδινυλ-αλκυλ-ουρεϊδο)-κινολινες ως ανταγωνιστες του υποδοχεα ουροτασινης ii | |
| DE68906609D1 (de) | Dopamin-vorlaeufer. | |
| HUP0500034A2 (hu) | N-Aril-N'-(aril-cikloalkil)-karbamid-származékok mint MCH antagonisták és ezeket hatóanyagként tartalmazó gyógyszerkészítmények | |
| BG101867A (bg) | Бензотиазиндиоксиди като антагонисти на ендотелин | |
| SE0101038D0 (sv) | Novel compounds | |
| DE69703228D1 (de) | Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon | |
| ATE309339T1 (de) | Thrombomodulin analoga und ihre pharmazeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010. |